T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.62B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$1.61B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Lam Research
LRCX
|
+$1.17B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$1.4B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Tesla
TSLA
|
+$1.13B |
| 4 |
JPMorgan Chase
JPM
|
+$1.11B |
| 5 |
Morgan Stanley
MS
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 15.14% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
TriNet
TNET
$3.07B
| $339K | ﹤0.01% |
+6,055
| New | +$319K |
|
2302
BancFirst
BANF
$3.84B
| $338K | ﹤0.01% |
5,703
+23
| +0.4% | +$1.35K |
|
2303
Heron Therapeutics
HRTX
$64.7M
| $338K | ﹤0.01% |
+8,703
| New | +$277K |
|
2304
Central Pacific Financial
CPF
$997M
| $337K | ﹤0.01% |
11,765
+31
| +0.3% | +$917 |
|
|
INN
2305
Summit Hotel Properties
INN
$655M
| $337K | ﹤0.01% |
23,564
+1,685
| +8% | +$24.4K |
|
|
ACRE
2306
Ares Commercial Real Estate
ACRE
$261M
| $336K | ﹤0.01% |
24,365
+29
| +0.1% | +$384 |
|
|
FRED
2307
DELISTED
Fred's Inc
FRED
| $336K | ﹤0.01% |
147,225
+61,730
| +72% | +$134K |
|
|
GG
2308
DELISTED
Goldcorp Inc
GG
| $335K | ﹤0.01% |
24,400
| – | – |
|
2309
Oxford Industries
OXM
$538M
| $333K | ﹤0.01% |
4,008
+70
| +2% | +$5.64K |
|
2310
Anika Therapeutics
ANIK
$295M
| $332K | ﹤0.01% |
+10,384
| New | +$428K |
|
2311
NVE Corp
NVEC
$591M
| $332K | ﹤0.01% |
2,727
+5
| +0.2% | +$499 |
|
|
PHH
2312
DELISTED
PHH Corporation
PHH
| $332K | ﹤0.01% |
30,568
+13,235
| +76% | +$142K |
|
|
BNFT
2313
DELISTED
Benefitfocus, Inc.
BNFT
| $330K | ﹤0.01% |
9,830
+54
| +0.6% | +$1.69K |
|
|
BRS
2314
DELISTED
Bristow Group, Inc.
BRS
| $330K | ﹤0.01% |
23,388
+12,135
| +108% | +$181K |
|
2315
Griffon
GFF
$4.75B
| $329K | ﹤0.01% |
18,482
+132
| +0.7% | +$2.72K |
|
|
CALA
2316
DELISTED
Calithera Biosciences, Inc
CALA
| $329K | ﹤0.01% |
3,287
+215
| +7% | +$24.4K |
|
2317
Hurco Companies Inc
HURC
$144M
| $328K | ﹤0.01% |
7,329
+7
| +0.1% | +$322 |
|
2318
NN Inc
NNBR
$302M
| $328K | ﹤0.01% |
17,375
+29
| +0.2% | +$625 |
|
|
SIGM
2319
DELISTED
Sigma Designs Inc
SIGM
| $328K | ﹤0.01% |
53,816
+43
| +0.1% | +$267 |
|
2320
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $327K | ﹤0.01% |
13,500
-5,700
| -30% | -$146K |
|
2321
BioLife Solutions
BLFS
$1.71B
| $322K | ﹤0.01% |
28,200
| – | – |
|
2322
Methanex
MEOH
$4.17B
| $317K | ﹤0.01% |
4,484
+100
| +2% | +$6.71K |
|
|
DERM
2323
DELISTED
Dermira, Inc.
DERM
| $317K | ﹤0.01% |
34,473
-316,554
| -90% | -$2.95M |
|
2324
AMES National
ATLO
$281M
| $316K | ﹤0.01% |
10,250
+9
| +0.1% | +$263 |
|
|
UHT
2325
Universal Health Realty Income Trust
UHT
$573M
| $315K | ﹤0.01% |
4,924
+14
| +0.3% | +$863 |
|
Similar funds
T. Rowe Price Associates's Q2 2018 Portfolio in Review
As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
- T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
- T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
- T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.
Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.